Effects of Epsilon Aminocaproic Acid (EACA) and Trasylol on Thromboplastin‐Induced Intravascular Coagulation, Studied in Dogs with Iodine‐Labelled Fibrinogen

This publication has 18 references indexed in Scilit:

• Turnover of 131I-Labelled Fibrinogen in Man: Studies in Normal Subjects, in Congenital Coagulation Factor Deficiency States, in Liver Cirrhosis, in Polycythemia Vera and in Epidermolysis Bullosa1
  Acta Medica Scandinavica, 2009
• Incorporation of 131I into Dog Fibrinopeptides.
  Acta Chemica Scandinavica, 1969
• EXPERIMENTAL INVESTIGATIONS ON THE ANTITHROMBOPLASTIC AND ANTIFIBRINOLYTIC ACTIVITY OF TRASYLOL®
  Annals of the New York Academy of Sciences, 1968
• In vitro and In vivo Studies with Trasylol, an Anticoagulant and a Fibrinolytic Inhibitor
  British Journal of Haematology, 1968
• Experimental and Clinical Studies on the Antifibrinolytic and Presumed Antithrombotic Effect of a Kallikrein Inhibitor (Trasylol)
  Scandinavian Journal of Urology and Nephrology, 1967
• Cardiovascular studies on aminocaproic acid
  Toxicology and Applied Pharmacology, 1966
• A New Method for Fractionation of Proteins.
  Acta Chemica Scandinavica, 1966
• Acceleration of Fibrin Polymerization by Acetate and other Low Molecular Ions
  Scandinavian Journal of Clinical and Laboratory Investigation, 1964
• The Influence of Fibrinogenolytic and Fibrinolytic Split Products on the Last Stage of Coagulation
  Scandinavian Journal of Clinical and Laboratory Investigation, 1963
• A Quantitative One-Stage Method for the Assay of Prothrombin
  Scandinavian Journal of Clinical and Laboratory Investigation, 1949